Achieve Life Sciences, Inc. (QUIT) stock forecast and price target
Price $6.32 · data as of November 13, 2026
12-month price target
Average target$14.58
Upside / downside+130.7%
Analysts12
ConsensusStrong buy
Low $10.00Average $14.58High $21.00
Gold marker: average target · white marker: today’s price ($6.32)
Analyst ratings
Strong buy 3Buy 8Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.34 | −7.4% | $0 |
| Next fiscal year ends December 31, 2027 | $-0.68 | +49.1% | $32M |
| Next quarter ends December 31, 2026 | $-0.22 | +22.4% | $0 |
| Quarter after ends March 31, 2027 | $-0.18 | +4.5% | $2M |
Consensus of the analysts covering Achieve Life Sciences, updated daily.
Frequently asked questions
What is the Achieve Life Sciences stock price target?
The average 12-month target from 12 analysts is $14.58, 130.7% above the current price of $6.32 Targets range from $10.00 to $21.00.
Is Achieve Life Sciences a buy according to analysts?
The consensus rating is “Strong buy” (3 strong buy, 8 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Achieve Life Sciences expected to earn?
Analysts expect EPS of $-1.34 for the fiscal year ending December 31, 2026 and $-0.68 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.